​

Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?

OverviewForecastRevenueFinancialsChart

Jasper Therapeutics Ownership Summary

Jasper Therapeutics is owned by 24.96% institutional investors, 1.05% insiders, and 74.00% retail investors. Velan capital investment management lp is the largest institutional shareholder, holding 17.76% of JSPR shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.

JSPR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockJasper Therapeutics24.96%1.05%74.00%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Velan capital investment management lp2.67M17.76%$6.21M
Soleus capital management1.49M9.95%$3.56M
Acorn capital advisors1.38M9.20%$3.29M
Kingdon capital management1.32M8.82%$3.15M
Rock springs capital management lp1.10M7.33%$2.62M
Carlyle group1.07M7.10%$2.53M
Woodline partners lp1.04M6.92%$2.47M
Vanguard group1.03M6.88%$2.46M
T. rowe price investment management1.03M6.85%$2.45M
Propel bio management1.03M6.85%$2.45M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp2.67M5.83%$6.21M
Lion point capital, lp398.56K5.39%$948.57K
Qiming u.s. ventures management928.96K3.97%$2.21M
Propel bio management1.03M2.45%$2.45M
Acorn capital advisors1.38M1.67%$3.29M
Kingdon capital management1.32M0.39%$3.15M
Sphera funds management629.47K0.32%$1.50M
Soleus capital management1.49M0.18%$3.56M
Knott david m jr171.39K0.16%$407.91K
Rock springs capital management lp1.10M0.15%$2.62M

Top Buyers

HolderShares% AssetsChange
Acorn capital advisors1.38M1.67%1.38M
Velan capital investment management lp2.67M5.83%1.23M
Woodline partners lp1.04M0.01%1.04M
Propel bio management1.03M2.45%1.03M
Kingdon capital management1.32M0.39%640.14K

Top Sellers

HolderShares% AssetsChange
Braidwell lp---714.66K
Integral health asset management---590.00K
Samsara biocapital---584.64K
Franklin resources---534.71K
Opaleye management---400.00K

New Positions

HolderShares% AssetsChangeValue
Acorn capital advisors1.38M1.67%1.38M$3.29M
Woodline partners lp1.04M0.01%1.04M$2.47M
Propel bio management1.03M2.45%1.03M$2.45M
Simplify asset management609.05K0.03%609.05K$1.45M
Boothbay fund management442.64K0.02%442.64K$1.05M

Sold Out

HolderChange
Sterling capital management-12.00
Wolff wiese magana-15.00
Coldstream capital management-38.00
Eversource wealth advisors-65.00
Greenline partners-100.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202512-80.33%3,749,017-66.07%240.46%6-81.82%3-78.57%
Jun 30, 202565-2.99%12,501,1538.39%831.33%3516.67%15-34.78%
Mar 31, 202570-24.73%13,034,411-16.69%890.78%32-38.46%2335.29%
Dec 31, 20249210.84%15,645,9346.60%1071.12%5115.91%17-10.53%
Sep 30, 20248318.57%14,676,9540.82%971.04%44-19111.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Polar Capital Healthcare Opports Inc581.54K3.85%-
T. Rowe Price Small-Cap Value437.64K2.91%-512.00
Vanguard Total Stock Mkt Idx Inv412.11K2.54%-9.01K
Franklin Biotechnology Discv A(acc)USD339.25K2.26%-
iShares Russell 2000 ETF285.63K1.90%-
HBM Healthcare Investments AG Ord250.00K1.67%-
T. Rowe Price U.S. SC Value Eq Tr-D247.05K1.64%1.24K
T. Rowe Price U.S. SC Value Eq Tr-Z245.81K1.64%217.41K
Fidelity Select Health Care208.04K1.39%208.04K
Franklin Biotechnology Discovery A195.44K1.30%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 22, 2025WIGGANS THOMAS G-Buy$119.72K
Sep 22, 2025WIGGANS THOMAS G-Buy$99.63K
Sep 22, 2025Lucas Svetlana-Buy$48.60K
Sep 22, 2025Lucas Svetlana-Buy$58.40K
Sep 22, 2025MARTELL RON President and CEOBuy$99.63K

Insider Transactions Trends

DateBuySell
2025 Q38-
2025 Q2--
2025 Q1--
2024 Q4-1
2024 Q3-1

JSPR Ownership FAQ

Who Owns Jasper Therapeutics?

Jasper Therapeutics shareholders are primarily institutional investors at 24.96%, followed by 1.05% insiders and 73.99% retail investors. The average institutional ownership in Jasper Therapeutics's industry, Biotech Stocks , is 45.24%, which Jasper Therapeutics falls below.

Who owns the most shares of Jasper Therapeutics?

Jasper Therapeutics’s largest shareholders are Velan capital investment management lp (2.67M shares, 17.76%), Soleus capital management (1.49M shares, 9.95%), and Acorn capital advisors (1.38M shares, 9.20%). Together, they hold 36.92% of Jasper Therapeutics’s total shares outstanding.

Does Blackrock own Jasper Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Jasper Therapeutics.

Who is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.83% of its assets in 2.67M Jasper Therapeutics shares, valued at 6.21M$.

Who is the top mutual fund holder of Jasper Therapeutics shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Jasper Therapeutics shares, with 3.85% of its total shares outstanding invested in 581.54K Jasper Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools